Parse Biosciences, the leading provider of scalable and accessible single cell sequencing solutions, today launched the next generation of its Evercode™ TCR and Evercode™ BCR kits, shipping to ...
(NASDAQ: ILMN) today announced the launch of the StrataMap Spatial Solution, offering an unmatched breadth of coverage and ...
Combines BioSkyrb’s new ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit 384-well assay with Uno Single Cell Dispenser™ provided by Tecan in a single workflow Enables scalable, ...
Parse Biosciences introduces the next generation of its immune profiling kits: Seattle Thursday, June 11, 2026, 16:00 Hrs [IST] Parse Biosciences, the leading provider of scalable ...
Creative Biolabs, a leader in single-cell resolution solutions, has announced the strategic enhancement of its ...
Master Scaling Single-Cell Biology. This free webinar series covers multi-omic data integration, spatial datasets, and new AI ...
BioSkryb Genomics and Tecan Group, today introduced a high-throughput single-cell workflow, combining BioSkryb's 384-well format of the ResolveOME ™ Whole Genome and Transcriptome Single-Cell Core Kit ...
BioSkryb Genomics and Tecan report that they have introduced a high-throughput single-cell workflow, combining BioSkryb’s 384-well format of the ResolveOME™ whole genome and transcriptome single-cell ...
Outcomes of young-onset colorectal cancer vs late-onset colorectal cancer patients on phase 1 matched and non-matched therapies. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果